Sylwia Kwiatkowska

Sylwia Kwiatkowska

Auto-generated profile, based on publicly available information

Sylwia Kwiatkowska

Clinical Pneumonology Ward, Medical University od Łódź, Kopcińskiego 22, 90-153 Łódź, Poland.

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in Respiratory Medicine
Verified
Journal Article
Closed access
MZM. Zieba
M. Zieba
MSM. Suwalski
M. Suwalski
SKS. Kwiatkowska
S. Kwiatkowska
GPG. Piasecka
G. Piasecka
IGI. Grzelewska–Rzymowska
I. Grzelewska–Rzymowska
DND. Nowak
D. Nowak

1 April 1999 in Respiratory Medicine
Verified
Journal Article
Closed access
SKS. Kwiatkowska
S. Kwiatkowska
GPG. Piasecka
G. Piasecka
MZM. Zieba
M. Zieba
Wojciech PiotrowskiWojciech Piotrowski
Wojciech Piotrowski
DNDariusz Nowak
Dariusz Nowak

1 August 2002
Verified
Journal Article
Closed access
EHE Hrabec
E Hrabec
MSM Strek
M Strek
MZM Zieba
M Zieba
SKS Kwiatkowska
S Kwiatkowska
ZHZ Hrabec
Z Hrabec

24 July 2012 in Respiration
Verified
Journal Article
Closed access
PDF file
SKS. Kwiatkowska
S. Kwiatkowska
KNK. Noweta
K. Noweta
MZM. Zieba
M. Zieba
DNDariusz Nowak
Dariusz Nowak
PBPiotr Bialasiewicz
Piotr Bialasiewicz
Background: Matrix metalloproteinase-9 (MMP-9) and its inhibitor tissue inhibitor of metalloproteinase-1 (TIMP-1) are involved in the pathogenesis of airway inflammation in patients with chronic obstructive pulmonary disease (COPD). However, no study so far has addressed their value as noninvasive biomarkers of airways inflammation. Objective: To evaluate MMP-9 and TIMP-1 concentrations in the exhaled breath condensate (EBC) of patients with stable COPD and also during the exacerbation episode. Methods: EBC and serum samples were collected in 17 stable-phase COPD patients who were current smokers as well as during their first exacerbation episode, and in 22 asymptomatic smokers. EBC and serum levels of MMP-9 and TIMP-1 were measured with ELISA kit. Results: Mean EBC MMP-9 and TIMP-1 levels were higher in patients with stable COPD than in asymptomatic smokers. Exacerbation of COPD increased 2-fold the exhalation of MMP-9 (18.5 ± 10.1 ng/ml vs. 8.9 ± 6.2 ng/ml, p = 0.01) and TIMP-1 (to 41.1 ± 20.4 ng/ml vs. 16.4 ± 6.8 ng/ml, p < 0.001). Both, MMP-9 and TIMP-1 in EBC correlated negatively with FEV1 (% predicted) at baseline (r = –0.78, p < 0.001 and r = –0.73, p < 0.001) and during the exacerbation episode (r = –0.57, p = 0.02 and r = –0.65, p = 0.005). Similar negative correlations were noted with FVC (% predicted), except for MMP-9 in EBC at exacerbation. Exhaled MMP-9 and TIMP-1 did not correlate with serum concentrations in COPD patients, either at baseline or during exacerbation. Conclusion: Exhaled MMP-9 and TIMP-1 increased during COPD exacerbation and was negatively correlated with spirometric variables, which suggests the usefulness of their measurement in EBC for the monitoring of airways inflammation. However, to better assess their diagnostic or prognostic value larger studies are necessary.

1 March 2007 in Respiratory Medicine
Verified
Journal Article
Closed access
SKS. Kwiatkowska
S. Kwiatkowska
USU. Szkudlarek
U. Szkudlarek
MŁM. Łuczyńska
M. Łuczyńska
DNDariusz Nowak
Dariusz Nowak
MZM. Zięba
M. Zięba

1 January 2014 in American Journal of Case Reports
Verified
Journal Article
Open access
PDF file
SKSylwia Kwiatkowska
Sylwia Kwiatkowska
Wojciech PiotrowskiWojciech Piotrowski
Wojciech Piotrowski
PGPaweł Górski
Paweł Górski
JDJoanna Duda-Szymańska
Joanna Duda-Szymańska
Background:Sarcoidosis is a granulomatous inflammatory disease that is induced by unknown antigen(s) in a genetically susceptible host. Although the direct link between Mycobacterium tuberculosis (MTB) infection and sarcoidosis can be excluded on the...